Your browser doesn't support javascript.
loading
A Bayesian hierarchical approach to account for evidence and uncertainty in the modeling of infectious diseases: An application to COVID-19.
Rehms, Raphael; Ellenbach, Nicole; Rehfuess, Eva; Burns, Jacob; Mansmann, Ulrich; Hoffmann, Sabine.
Affiliation
  • Rehms R; Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), Faculty of Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Ellenbach N; Pettenkofer School of Public Health, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Rehfuess E; Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), Faculty of Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Burns J; Pettenkofer School of Public Health, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Mansmann U; Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), Faculty of Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Hoffmann S; Pettenkofer School of Public Health, Ludwig-Maximilians-University Munich, Munich, Germany.
Biom J ; 66(1): e2200341, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38285407
ABSTRACT
Infectious disease models can serve as critical tools to predict the development of cases and associated healthcare demand and to determine the set of nonpharmaceutical interventions (NPIs) that is most effective in slowing the spread of an infectious agent. Current approaches to estimate NPI effects typically focus on relatively short time periods and either on the number of reported cases, deaths, intensive care occupancy, or hospital occupancy as a single indicator of disease transmission. In this work, we propose a Bayesian hierarchical model that integrates multiple outcomes and complementary sources of information in the estimation of the true and unknown number of infections while accounting for time-varying underreporting and weekday-specific delays in reported cases and deaths, allowing us to estimate the number of infections on a daily basis rather than having to smooth the data. To address dynamic changes occurring over long periods of time, we account for the spread of new variants, seasonality, and time-varying differences in host susceptibility. We implement a Markov chain Monte Carlo algorithm to conduct Bayesian inference and illustrate the proposed approach with data on COVID-19 from 20 European countries. The approach shows good performance on simulated data and produces posterior predictions that show a good fit to reported cases, deaths, hospital, and intensive care occupancy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Communicable Diseases / COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Biom J Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Communicable Diseases / COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Biom J Year: 2024 Document type: Article